Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending June 30, 2021, with the specific event reported occurring on June 9, 2021. The filing serves as a notice of a capital increase approved by the Board of Directors resulting from the exercise of stock options by beneficiaries under the Company's Stock Option Plan and the "Second Program of Stock Options of the Company for the year 2014."
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.
- Total Capital Increase: R$ 3,581,054.80
- Total New Shares Issued: 284,552 common shares (no par value)
- Issuance Prices: R$ 11.97200 and R$ 16.85000 per share
- Post-Issuance Capital Stock: R$ 57,976,697,974.70
Material Changes
The primary material change is the increase in authorized capital and issued share count due to the exercise of options. The potential dilution arising from this issuance is negligible:
- Dilution vs. Issued Shares: 0.001940%
- Dilution vs. Capital Stock: 0.000996%
Historical share price data indicates volatility over the last three years, with the average price in 2020 (R$ 15.66) lower than in 2019 (R$ 18.73) and 2018 (R$ 15.39). The average price for the first quarter of 2021 was R$ 15.31.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a procedural disclosure regarding the verification of share issuance and the reporting of historical market prices adjusted for interest on shareholder's equity and dividend distributions.
Investor Verification Checklist
- Verify the total number of new shares issued (284,552) against the company's updated capitalization table.
- Confirm the issuance prices (R$ 11.97 and R$ 16.85) align with the strike prices of the specific option plans exercised.
- Review the negligible dilution impact (approx. 0.002%) to confirm it does not materially affect existing shareholder value.
- Check subsequent filings for the impact of this capital increase on earnings per share (EPS) calculations.